We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
Cap. Flow
-$364M
Cap. Flow %
-7.78%
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$25.2M
2
ASH icon
Ashland
ASH
+$17.2M
3
IBM icon
IBM
IBM
+$17.1M
4
MSGS icon
Madison Square Garden
MSGS
+$16.7M
5
VLO icon
Valero Energy
VLO
+$16.1M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$35.9M
2
QCOM icon
Qualcomm
QCOM
+$29M
3
BCR
CR Bard Inc.
BCR
+$27.5M
4
A icon
Agilent Technologies
A
+$26.4M
5
NOC icon
Northrop Grumman
NOC
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Financials 19.14%
3 Healthcare 11.97%
4 Industrials 11.47%
5 Consumer Discretionary 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALPN
876
DELISTED
Alpine Immune Sciences Inc
ALPN
$141K ﹤0.01%
14,606
-3,570
-20% -$34.2K
ALSK
877
DELISTED
Alaska Communications Systems
ALSK
$141K ﹤0.01%
64,158
– –
SUNE
878
SUNation Energy
SUNE
$10.7M
– –
0
– –
YUME
879
DELISTED
YuMe, Inc.
YUME
$137K ﹤0.01%
29,100
+18,500
+175% +$81.7K
PMBC
880
DELISTED
Pacific Mercantile Bancorp
PMBC
$136K ﹤0.01%
+15,443
New +$122K
CHMA
881
DELISTED
Chiasma, Inc. Common Stock
CHMA
$136K ﹤0.01%
93,931
+29,755
+46% +$45.1K
SCX
882
DELISTED
The L.S. Starrett Company
SCX
$134K ﹤0.01%
15,572
+4,982
+47% +$46.5K
TTNP
883
DELISTED
Titan Pharmaceuticals
TTNP
$130K ﹤0.01%
+19
New +$177K
TST
884
DELISTED
TheStreet, Inc.
TST
$129K ﹤0.01%
15,591
+11,252
+259% +$95.2K
TCON
885
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$124K ﹤0.01%
258
+170
+193% +$104K
KPTI icon
886
Karyopharm Therapeutics
KPTI
$161M
$119K ﹤0.01%
880
-636
-42% -$94.1K
MRVC
887
DELISTED
MRV Communications Inc
MRVC
$119K ﹤0.01%
12,058
– –
QNST icon
888
QuinStreet
QNST
$861M
$115K ﹤0.01%
27,624
-23,238
-46% -$93.3K
DXLG icon
889
Destination XL Group
DXLG
$34.5M
$114K ﹤0.01%
48,566
-25,186
-34% -$61.7K
RGS icon
890
Regis Corp
RGS
$68.8M
$110K ﹤0.01%
535
-140
-21% -$28.8K
RXDX
891
DELISTED
Ignyta, Inc.
RXDX
$109K ﹤0.01%
10,510
-15,038
-59% -$122K
AGTC
892
DELISTED
Applied Genetic Technologies Corporation
AGTC
$107K ﹤0.01%
20,900
-5,900
-22% -$33.1K
LSTA icon
893
Lisata Therapeutics
LSTA
$19.3M
$106K ﹤0.01%
1,526
+325
+27% +$23K
CBK
894
DELISTED
Christopher & Banks Corporation
CBK
$101K ﹤0.01%
76,893
+65,793
+593% +$83.7K
UBFO
895
DELISTED
United Security Bancshares
UBFO
$100K ﹤0.01%
+10,859
New +$95.3K
AGEN
896
Agenus
AGEN
$258M
$98K ﹤0.01%
+1,279
New +$89.9K
ATRS
897
DELISTED
Antares Pharma, Inc.
ATRS
$93K ﹤0.01%
28,970
-109,542
-79% -$310K
PRSS
898
DELISTED
CafePress Inc.
PRSS
$93K ﹤0.01%
37,680
+6,638
+21% +$17.7K
ARQL
899
DELISTED
Arqule Inc
ARQL
$87K ﹤0.01%
70,240
+33,388
+91% +$36.4K
HNRG icon
900
Hallador Energy
HNRG
$756M
$80K ﹤0.01%
+10,293
New +$77.2K
34 35
36
37 38

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q2 2017 Portfolio in Review

As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.

  • Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
  • Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
  • Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
  • Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
  • Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
  • Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.